تحميل...
Syrosingopine sensitizes cancer cells to killing by metformin
We report that the anticancer activity of the widely used diabetic drug metformin is strongly potentiated by syrosingopine. Synthetic lethality elicited by combining the two drugs is synergistic and specific to transformed cells. This effect is unrelated to syrosingopine’s known role as an inhibitor...
محفوظ في:
| الحاوية / القاعدة: | Sci Adv |
|---|---|
| المؤلفون الرئيسيون: | , , , , , , , , , , , , , |
| التنسيق: | Artigo |
| اللغة: | Inglês |
| منشور في: |
American Association for the Advancement of Science
2016
|
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5182053/ https://ncbi.nlm.nih.gov/pubmed/28028542 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/sciadv.1601756 |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|